Division of Division of Liver Disease & Transplant Hepatology
Department of Medicine
Division of Liver Disease & Transplant Hepatology
Welcome to the Rutgers-New Jersey Medical School, Department of Medicine, Division of Liver Disease & Transplant Hepatology website. Since its inception, the Division of Liver Disease & Transplant Hepatology has focused on providing excellent care for individuals with liver disease, as well as patients who require liver transplantation. Our physicians and staff have decades of experience in managing all varieties of liver disease including viral, alcoholic, metabolic, drug induced, and immune mediated diseases. In addition, we specialize in the management of patients with complications of portal hypertension, end-stage liver disease, and hepatocellular and biliary tract carcinoma. We are proud of the outstanding success of our Liver Transplantation program which is nationally recognized for outstanding patient and graft survival. We have a strong commitment to our patients, their families, and the surrounding community.
In addition to providing outstanding patient care, the Division of Liver Disease & Transplant Hepatology is dedicated to the advancement of the field of Hepatology and Liver Transplantation based on our commitment to clinical and basic science research. We are participating in multiple clinical studies for various liver diseases, providing our patients access to new treatments. The division's focus on training future Hepatologists is exemplified by the fact that we have the largest Digestive Disease fellowship program in the state of New Jersey, and we provide education to countless numbers of medical students, interns, residents and visiting fellows.
Physicians at Rutgers New Jersey Medical School achieve highest one-year survival rate
The liver transplant program at Rutgers-affiliated University Hospital in Newark was ranked first in the nation, along with Harvard-affiliated Beth Israel Deaconess Medical Center in Boston, for its one-year patient survival rate, according to data from the Scientific Registry of Transplant Recipients (SRTR).
Read More
The Impact of COVID on Successful Liver Transplantation
Steve Adubato is joined by Nick Pyrsopoulos, MD, PhD, MBA, Medical Director, Liver Transplant Program, University Hospital, and James V. Guarrera, MD, Chief of Service for Surgery, Surgical Director, Liver Transplantation, University Hospital. They discuss the success of their liver transplant program, the impact of COVID on transplantation, and the importance of research collaboration.
